BFC Planning, Inc.’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Sell
4,482
-614
-12% -$41.9K 0.01% 739
2026
Q1
$329K Sell
5,096
-1,046
-17% -$73.7K 0.01% 696
2025
Q4
$413K Buy
6,142
+187
+3% +$12.6K 0.02% 606
2025
Q3
$437K Buy
5,955
+664
+13% +$44.1K 0.03% 419
2025
Q2
$275K Sell
5,291
-51
-1% -$2.9K 0.02% 516
2025
Q1
$341K Buy
5,342
+531
+11% +$30.8K 0.03% 432
2024
Q4
$230K Buy
+4,811
New +$247K 0.02% 559

Other funds holding HALO

BFC Planning, Inc.'s HALO Position: Q2 2026 in Review

BFC Planning, Inc. reduced its Halozyme (HALO) stake by 12% in Q2 2026, selling an estimated $41.9K and leaving 4,482 shares worth $351K. The position accounts for 0.01% of the portfolio, ranked #739.

BFC Planning, Inc. first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. The position peaked at $437K in Q3 2025. 678 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • BFC Planning, Inc. held 4,482 shares of Halozyme worth $351K as of Q2 2026.
  • BFC Planning, Inc. sold 614 Halozyme shares in Q2 2026, an estimated $41.9K.
  • Halozyme made up 0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #739 holding.
  • BFC Planning, Inc. first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Halozyme position peaked at $437K in Q3 2025.
  • 678 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.